Emily A. Goode

Fulham Road
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Journal: Nature communications
Published: January 08, 2025

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells.

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells.

Journal: Cancers
Published: July 18, 2024

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.

Journal: EBioMedicine
Published: July 07, 2023

Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.

Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.

Journal: Glycobiology
Published: April 26, 2023

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.

Journal: Oncogene
Published: September 22, 2022

Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids.

Tropism of AAV Vectors in Photoreceptor-Like Cells of Human iPSC-Derived Retinal Organoids.

Journal: Translational vision science & technology
Published: April 04, 2022

Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.

Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.

Journal: Nature genetics
Published: February 02, 2020

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study.

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study.

Journal: Clinical colorectal cancer
Published: February 15, 2017

The cost of ipilimumab toxicity: a single-centre analysis.

The cost of ipilimumab toxicity: a single-centre analysis.

Journal: Melanoma research
Published: April 11, 2015
Showing 1-9 of 9

Last Updated: 09/26/2026